Search Results - Cortes, J.
- Showing 1 - 4 results of 4
-
1
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative br... by Dent, Rebecca (Author) , André, F. (Author) , Gonçalves, A. (Author) , Martin, M. (Author) , Schmid, P. (Author) , Schütz, Florian (Author) , Kümmel, S. (Author) , Swain, S. M. (Author) , Bilici, A. (Author) , Loirat, D. (Author) , Villalobos Valencia, R. (Author) , Im, S. -A. (Author) , Park, Y. H. (Author) , De Laurentis, M. (Author) , Colleoni, M. (Author) , Guarneri, V. (Author) , Bianchini, G. (Author) , Li, H. (Author) , Kirchmayer Machackova, Z. (Author) , Mouta, J. (Author) , Deurloo, R. (Author) , Gan, X. (Author) , Fan, M. (Author) , Mani, A. (Author) , Swat, A. (Author) , Cortés, J. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Nab-paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from t... by Yardley, Denise (Author) , Coleman, R. (Author) , Conte, P. (Author) , Cortes, J. (Author) , Brufsky, A. (Author) , Shtivelband, M. (Author) , Young, R. (Author) , Bengala, C. (Author) , Ali, H. (Author) , Eakel, J. (Author) , Schneeweiss, Andreas (Author) , de la Cruz-Merino, L. (Author) , Wilks, S. (Author) , O’Shaughnessy, J. (Author) , Glück, S. (Author) , Li, H. (Author) , Miller, J. (Author) , Barton, D. (Author) , Harbeck, N. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: recommendations from a panel of experts by Arpino, Grazia (Author) , Marmé, Frederik (Author) , Cortés, J. (Author) , Ricevuto, E. (Author) , Leonard, R. (Author) , Llombart-Cussac, A. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
4
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early brea... by Schneeweiss, Andreas (Author) , Chia, S. (Author) , Hickish, T. (Author) , Harvey, V. (Author) , Eniu, A. (Author) , Hegg, R. (Author) , Tausch, C. (Author) , Seo, J. H. (Author) , Tsai, Y. -F. (Author) , Ratnayake, J. (Author) , McNally, V. (Author) , Ross, G. (Author) , Cortés, J. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource